Skip to main content

European Partnerships

The IPBS has been involved in many research networks under the European Commission’s Framework s, from the Fifth Framework Programme for research, technological development and demonstration activities (FP5) to Horizon 2020 projects.

These networks involve several teams from the TB & Infection Biology department, who are participating in European integrated projects fighting tuberculosis, particularly in some projects coordinated by the "Tuberculosis Vaccine Initiative", but also involve teams from the Cancer Biology department and Structural Biology & Biophysics department.

Since 2000, the TB & Infection Biology department of IPBS is part of the TBVAC Consortium. This consortium brings in a large number of key partners from excellent laboratories from Europe, but also  USA, Asia, Africa and Australia, many of which are global leaders in the field of tuberculosis. Scientists and developers from 40 research partners collaborate in TBVAC2020. The cuurrent 4-year project started in January 2015 and is coordinated by the Tuberculosis Vaccine Initiative (TBVI).


Since 2015, IPBS takes part in various European schemes, such as RESPIRE 2 and 3, and in the Initial Training Network (ITN) GLYCOGAN 


Based on a solid and old collaboration with the University of Ljubljana, the IPBS developed an European Associated Laboratory (LEA) entitled “Pulsed Electric Fields Applications in Biology and Medicine”, abbreviated as “LEA EBAM”. This French-Slovenian “without walls” laboratory has been created in January 2011 for four years and has been renewed for four additional years.


IPBS teams are also members of European programs of cross-border cooperation, through the interregional (Spain-France-Andorra) POCTEFA 2014-2020 created to promote the sustainable development of the border territories of the three countries on both sides of the Pyrenees.

Historically, starting with the 5th European Framework Programme (FP5) in 2000, the IPBS takes part to the global initiative against tuberculosis as one key partner of the “TB Vaccine Cluster”.


Between 2010 and 2014, the TB & Infection Biology department of IPBS had participated to the SYSTEMTB consortium, together with 12 renowned institutes such as the Max Planck (Germany), the medical research council (UK) etc.


Between 2008 and 2012, Prof. Alain Milon, the NMR team leader, coordinated an Initial Training Network (ITN) on the theme of Structural Biology of Membrane Proteins (SBMPs). This network involved 13 academic teams in Europe, and allowed the funding of 21 PhD scholarships and 14 postdoctoral fellowships, including 3 in the IPBS.


IPBS has also actively participated to the EU-Brazil project “TARKINAID” aimed at the understanding and treating Chronic autoimmune and inflammatory diseases such as rheumatoid arthritis or chronic inflammatory lung diseases.